CPT — Copyright/Patent/Trademark
Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269).
Lobbyists:
1st Quarter - Report · 2026
- Filing UUID
cf6cd7a5-d6ee-4ed0-b861-047a616e7182- Type
Q1— 1st Quarter - Report- Period
- first_quarter
- Year
- 2026
- Posted
- 2026-04-20 20:12:44
- Income (reported)
- $450,000
- Expenses (reported)
- —
- Filing document
- Open on lda.senate.gov
Registrant (lobbying firm)
Law firm
- Contact
- BRIAN SMITH
- Phone
- +1 202-662-5090
- Address
- zip:20001, city:Washington, state:DC, street:850 10th Street, NW
Client
PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC
- State
- DC
- Country
- US
- Government-entity client
- false
- Effective date
- 2007-08-13
Issues lobbied + lobbyists
HCR — Health Issues
Biosimilars Access and Affordability Act (S. 5459); Skinny Labels, Big Savings Act (S. 43/H.R. 6485); Eliminating Thickets to Increase Competition (ETHIC) Act (S. 2276/H.R. 3269); Expedited Access to Biosimilars Act (S. 1414); Biosimilar Red Tape Elimination Act (S. 1954/H.R. 5526); CLEAR Act (H.R.7140); Artificial Intelligence-Ready Data Act (S.4098); Preserve Access to Affordable Generics and Biosimilars Act (S. 1096); Drug Competition Enhancement Act (S.1040); America's Living Library Project Bill (S. 4023); Securing Essential Components for U.S. Readiness in Essential Pharmaceuticals (SECURE Rx) Act of 2026 (discussion draft); improvements to the National Childhood Vaccine Injury Act of 1986; Consumer Labeling for Enhanced API Reporting and Legitimate Accountability for Base Entity Listings (CLEAR LABELS) Act (S. 3788).
Lobbyists:
Government entities lobbied: SENATE